Dr. Daniel Skovronsky, Chief Scientific Officer of Lilly, the world's most valuable pharmaceutical company, stated with extreme optimism that a major breakthrough in the treatment of Alzheimer's disease is imminent and that the drug being developed may become the next hot spot similar to the weight loss miracle drug "GLP-1".